• Blame Suzanne Somers

    by Sharan Abdul-Rahman, MD
    on Sep 30th, 2015

Hormone therapy is effective in treating hot flashes, vaginal dryness and helping to prevent osteoporosis. There are commercially made FDA approved hormone therapies. However, the use of commercially made FDA approved hormone therapy has declined due to safety concerns, while the use of compounded/bioidentical hormones has increased.

The use of compounded/bioidentical hormones use has increased despite multiple health organizations including the American College of OBGYN and the US Preventive Services Task Force warnings about the lack of scientific evidence to support the use, efficacy and safety of compounded/bioidentical hormones.

A recent study evaluated the results of two online surveys given to peri- and postmenopausal women.

The first survey - the Harris survey was conducted in 2013 among women aged 45 to 60 years who had or were experiencing menopausal symptoms. The survey was sent to 10,781 women. Of the 10,000 plus women sent surveys, 801 women met the study criteria and completed the survey.

The second survey - the Rose survey was conducted in 2014 among women aged 40 and older who were former or current users of any type of menopause hormone therapy. The survey was sent to 90,210 women. Of the 90,000 plus women sent surveys, 2,044 women met the study criteria and completed the survey.

The majority of the women who completed the survey were white, menopausal (meaning their last period was more than one year ago) and in their fifties. The conclusions were extrapolated from these two surveys.

It was estimated that 1-2.5 million women were using compounded/bioidentical hormone therapy at a cost between $1- $2 billion dollars annually.

The majority of women completing the Rose survey obtained their information about hormone therapy from family and friends. When the women who completed the Harris survey were asked:
"Do you believe that bioidentical hormone therapies compounded at a specialty pharmacy are FDA approved?"

Among women completing the surveys the most frequently reported menopausal symptoms were:Hot flashes

The study suggests that the use of compounded/bioidentical hormones is substantial despite lacking FDA approval. Additionally, it suggests that women are unsure of the risks vs benefits of compounded/bioidentical versus commericially made hormone therapy. And lastly it suggests that we have a problem within our healthcare system when people either disregard or mistrust health information provided by nationally recognized health organizations.


Pinkerton,J et al. "Compounded bioidentical hormone therapy: Identifying use trends and knowledge gaps among US women" Menopause: The Journal of the North American Society. 2015; Vol.22: No.9, pp.926-936


Author Sharan Abdul-Rahman, MD

You Might Also Enjoy...

Why MonaLisa

Fractional CO2 laser treatment for symptomatic menopausal women.

Spring has sprung.

At some point you realize that it’s not about longevity but about the quality of your life. Live well.

MonaLisa Touch - FAQs

Frequently asked questions about the novel treatment for vulvar/vaginal changes due to menopause including vaginal dryness, buring, and pain with sex.

Location
Today's Woman
1015 Chestnut Street, Suite 907
Philadelphia, PA 19107
Phone: 267-388-2976
Office Hours

Get in touch

267-388-2976